Affiliation:
1. I. M. Sechenov First Moscow State Medical University, Ministry of Health of Russia
Abstract
The article presents updated data concerning the molecular mechanisms of influence of the well-known in clinical practice drug Mastodynon. The paper provides evidence of a significant effect of the compounds containing in its composition on the cell lines of a number of malignant neoplasms: breast cancer, hepatocellular carcinoma, leukemia and others. The data obtained are extremely attractive in the perspective of using the drug as a preventive agent.
Publisher
Publishing House ABV Press
Subject
Pharmacology (medical),Obstetrics and Gynecology,Radiology, Nuclear Medicine and imaging,Oncology,Surgery
Reference16 articles.
1. Global website of the World Health Organization. Available at: https://www.who.int/en
2. Sasaki Y., Takagi K., Akashira J.-I. et al. Immunolocalisation or estrogen-producing and metabolizing enzymes in bening breast disease: comparison with normal breast and breast сarcinoma. JCA 2010;101(10):2286–92. DOI: 10.1111/j.1349-7006.2010.01673.x
3. Kogan I.Yu. Mastopathy, new approaches to diagnostics and pathogenetic therapy. Journal of Zhurnal akusherstva i zheskikh bolezney = Obstetrics and Women’s Diseases 2010;LIX(1):66–70. (In Russ.)
4. Madaus G. Lehrbuch der biologischen Heilmittel. 4 Bände. Thieme, Leipzig, 1938.
5. Panay N. Guidelines on Premenstrual Syndrome. The National Association for Premenstrual Syndrome (NAPS), 2016. Available at: http://www.pms.org.uk/assets/files/guidelinesfinal60210.pdf
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献